Questcor Pharmaceuticals (QCOR) Jumps Higher on Analyst Defense
Tweet Send to a FriendGet Alerts QCOR Hot Sheet
Price: $37.21 -1.06%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
Revenue Growth %: +40.7%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 2.9%
Revenue Growth %: +40.7%
Trade QCOR Now!
Questcor Pharmaceuticals (Nasdaq: QCOR) is bouncing again on word analysts at BofA have confirmed that the company threatening to develop a generic form of ACTH is fraudulent.
While still down 3.4 percent, these comments are moving shares higher - something the earlier company JMP presentation was unable to do.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
While still down 3.4 percent, these comments are moving shares higher - something the earlier company JMP presentation was unable to do.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- UPDATE: Move Inc (MOVE) Higher, Citron Says Long on Twitter
- Canadian Solar (CSIQ) Continues Higher Following Arbitration Win Over LDK (LDK)
Create E-mail Alert Related Categories
Trader TalkRelated Entities
Bank of AmericaLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

